FDA Announces New Warnings For Popular Allergy Medication

PITTSBURGH (KDKA) — The Food and Drug Administration has strengthened existing warnings for a prescription medication for asthma and allergies.
The warnings are for Montelukast, known under the trade name of Singulair.
Montelukast/Singulair prescribing information already includes warnings about mental health side effects, including suicidal thoughts or actions; however, many health care professionals and patients/caregivers are not aware of the risk.The FDA decided a stronger warning is n